Scanlan Sean F.

Scanlan Sean F. is listed in filings as Chief Innovation Officer at Treace Medical Concepts, Inc.. This profile follows SEC Form 4 activity through Mar 11, 2026, including sale activity. Recent filings connect the profile to Treace Medical Concepts, Inc. (TMCI). The current snapshot covers public activity from Aug 9, 2024 to Mar 11, 2026. Reported amounts are shown as $17.7K to $24.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.